Factores asociados con el consumo de plantas medicinales para la prevención de COVID-19 en población peruana: un estudio transversal
DOI:
https://doi.org/10.17843/rpmesp.2024.411.13265Palabras clave:
COVID-19, SARS-CoV-2, Plantas medicinales, Medicina herbaria, Medicina tradicionalResumen
Objetivos. Determinar los factores asociados al consumo de plantas medicinales como prevención de la COVID-19 en la población peruana. Materiales y métodos. Se evaluó población mayor de 18 años, residentes en Perú y sin antecedentes de enfermedad por COVID-19. Los factores asociados al consumo de plantas medicinales se evaluaron mediante un modelo de regresión de Poisson con varianzas robustas. Resultados. De 3231 participantes incluidos, el 84,6% eran jóvenes (18-29 años), el 62,7% eran mujeres y el 59,7% consumía alguna planta medicinal para prevenir la COVID-19. Los factores asociados al consumo de plantas medicinales para prevenir el contagio de COVID-19 fueron residir en la sierra peruana, haber tenido un familiar diagnosticado con COVID-19, haber tenido un familiar fallecido por COVID-19, considerar que su familia se encuentra en mayor riesgo de infección, haber usado medicamentos o dióxido de cloro para
prevenir la COVID-19, tener información médica como principal fuente de información sobre la COVID-19, pensar que las plantas medicinales son efectivas para prevenir la enfermedad COVID-19 o no estar informado sobre su eficacia. Conclusión. El 60% de los participantes reportó haber consumido alguna planta medicinal para prevenir la COVID-19. Es importante que las autoridades apliquen estrategias de comunicación sobre lo que implica el consumo de plantas medicinales, priorizando los grupos poblacionales que tienen mayores patrones de consumo.
Descargas
Referencias
Arshad AS, Baloch M, Ahmed N, Arshad AA, Iqbal A. The outbreak of Coronavirus Disease 2019 (COVID-19)-An emerging global health threat. J Infect Public Health. 2020;13(4):644–646. doi: 10.1016/j.jiph.2020.02.033.
Ali I, Alharbi O. COVID-19: Disease, management, treatment, and social impact. Sci Total Environ. 2020;728:138861. doi: 10.1016/j.scitotenv. 2020.138861.
Asmundson G, Taylor S. Coronaphobia: Fear and the 2019-nCoV outbreak. J Anxiety Disord. 2020;70:102196. doi: 10.1016/j.janxdis.2020.102196.
Grigore A, Cord D, Tanase C, Albulescu R. Herbal medicine, a reliable support in COVID therapy. J Immunoassay Immunochem. 2020;41(6):976–979. doi: 10.1080/15321819.2020.1862867.
Oyebode O, Kandala NB, Chilton PJ, Lilford RJ. Use of traditional medicine in middle-income countries: a WHO-SAGE study. Health Policy Plan. 2016;31(8):984–991. doi: 10.1093/heapol/czw022.
Kretchy IA, Asiedu-Danso M, Kretchy JP. Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries. Res Social Adm Pharm. 2021;17(1):2023–2026. doi: 10.1016/j.sapharm.2020.04.007.
Oblitas G, Hernández-Córdova G, Chiclla A, Antich-Barrientos M, Ccorihuamán-Cusitito L, Romaní F. Use of medicinal plants among people attending two reference hospitals in Cusco, Peru. Rev Peru Med Exp Salud Publica. 2013;30(1):64-68. doi: 10.17843/rpmesp.2013.301.159.
Bussmann RW, Glenn A. Medicinal plants used in Peru for the treatment of respiratory disorders. Rev Peru Biol. 2010;17(3):331-346. http://www.scielo.org.pe/scielo.php?pid=S1727-99332010000300008&script=sci_abstract&tlng=en
Ruíz-Santillán MP, Mejía-Coico FR. Plantas utilizadas en medicina tradicional para afecciones respiratorias virales. REBIOL. 2020;40(1):109-130. https://revistas.unitru.edu.pe/index.php/facccbiol/article/view/3001.
Ministerio de Salud del Perú (MINSA). Prevención, diagnóstico y tratamiento de personas afectadas por COVID-19 en el Perú. Accessed August 18, 2022. https://www.gob.pe/institucion/minsa/informes-publicaciones/473587-prevencion-diagnostico-y-tratamiento-de-personas-afectadas-por-covid-19-en-el-peru.
Luján-Carpio E, Lizarraga-Castañeda Z, Mayor-Vega A, Medrano-Canchari K, Medina-Salazar H, Goicochea-Lugo S. Complementary medicine service in EsSalud, an alternative in the Peruvian health system. Rev Med Hered. 2014;25(2):105-106. http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1018-130X2014000200011.
Silveira D, Prieto-Garcia JM, Boylan F, Estrada O, Fonseca-Bazzo YM, Jamal CM, et al. COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy? Front Pharmacol. 2020;11:581840. doi: 10.3389/fphar.2020.581840.
Fernandez-Guzman D, Soriano-Moreno D, Ccami-Bernal F, Rojas-Miliano C, Sangster-Carrasco L, Hernández-Bustamante E, et al. Prácticas de prevención y control frente a la infección por Sars-Cov2 en la población peruana. Rev Cuerpo Med HNAAA. 2021;14(Sup1), 13 - 21. doi: 10.35434/rcmhnaaa.2021.14Sup1.1149.
Ahmed I, Hasan M, Akter R, Sarkar BK, Rahman M, Sarker MS, et al. Behavioral preventive measures and the use of medicines and herbal products among the public in response to Covid-19 in Bangladesh: A cross-sectional study. PloS one. 2020;15(12):e0243706. doi: 10.1371/journal.pone.0243706.
Villena-Tejada M, Vera-Ferchau I, Cardona-Rivero A, Zamalloa-Cornejo R, Quispe-Florez M, Frisancho-Triveño Z, et al. Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey. PLoS One. 2021;16(9):e0257165. doi: 10.1371/journal.pone.0257165.
Khadka D, Dhamala MK, Li F, Aryal PC, Magar PR, Bhatta S, et al. The use of medicinal plants to prevent COVID-19 in Nepal. J Ethnobiology Ethnomedicine. 2021;17:26. doi: 10.1186/s13002-021-00449-w.
Ang L, Song E, Lee HW, Lee MS. Herbal Medicine for the Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2020;9(5):1583. doi: 10.3390/jcm9051583.
Nugraha RV, Ridwansyah H, Ghozali M, Khairani AF, Atik N. Traditional Herbal Medicine Candidates as Complementary Treatments for COVID-19: A Review of Their Mechanisms, Pros and Cons. Evid Based Complement Alternat Med: eCAM. 2020;2020:2560645. doi:10.1155/2020/2560645.
Valenzuela-Oré F, Romaní-Romaní F, Monteza-Facho BM, Fuentes-Delgado D, Vilchez-Buitron E, Salaverry-García O. Cultural practices linked to health care and perception on the attention health facilities in residents of highandean settlements in Huancavelica, Peru. Rev Peru Med Exp Salud Publica. 2018;35(1):84-92. doi: 10.17843/rpmesp.2018.351.3603.
Santiváñez-Acosta R, Valenzuela-Oré F, Angulo-Bazán Y. Use of complementary and alternative medicine therapies in the Coronel Portillo province, Ucayali, Peru. Rev Peru Med Exp Salud Publica. 2020;37(3):510-515. doi: 10.17843/rpmesp.2020.373.4939.
Bendezu-Quispe G, Benites-Meza JK, Urrunaga-Pastor D, Herrera-Añazco P, Uyen-Cateriano A, Rodriguez-Morales AJ, et al. Consumption of Herbal Supplements or Homeopathic Remedies to Prevent COVID-19 and Intention of Vaccination for COVID-19 in Latin America and the Caribbean. Trop Med Infect Dis. 2022;7(6):95. doi: 10.3390/tropicalmed7060095.
Alyami HS, Orabi M, Aldhabbah FM, Alturki HN, Aburas WI, Alfayez AI, et al. Knowledge about COVID-19 and beliefs about and use of herbal products during the COVID-19 pandemic: A cross-sectional study in Saudi Arabia. Saudi Pharm J. 2020;28(11):1326–1332. doi: 10.1016/j.jsps.2020.08.023.
Corroto F, Gamarra Torres OA, Macía MJ. Different patterns in medicinal plant use along an elevational gradient in northern Peruvian Andes. J Ethnopharmacol. 2019;239:111924. doi: 10.1016/j.jep.2019.111924.
Huamantupa I, Cuba M, Urrunaga R, Paz E, Ananya N, Callalli M, et al. Richness, use and origin of expended medicinal plants in the markets of the Cusco City. Rev Peru Biol. 2011;18(3):283-292. http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1727-99332011000300004.
Mathez-Stiefel SL, Vandebroek I. Distribution and transmission of medicinal plant knowledge in the andean highlands: a case study from peru and bolivia. Evid Based Complement Alternat Med. 2012;2012:959285. doi: 10.1155/2012/959285.
Sõukand R, Kalle R. Herbal Landscape: The Perception of Landscape as a Source of Medicinal Plants. Trames Journal of the Humanities and Social Sciences. 2010;14:207-226. doi: 10.3176/tr.2010.3.01
Jauregui X, Clavo ZM, Jovel EM, Pardo-de-Santayana M. “Plantas con madre”: plants that teach and guide in the shamanic initiation process in the East-Central Peruvian Amazon. J Ethnopharmacol. 2011;134(3):739–752. doi: 10.1016/j.jep.2011.01.042.
Tello-Ceron G, Flores-Pimentel M, Gómez-Galarza V. Use of medicinal plants from the district of Quero, Jauja, Junín Region, Peru. Ecol Apl. 2019;18(1):11-20. http://www.scielo.org.pe/scielo.php?pid=S1726-22162019000100002&script=sci_arttext.
Alonso-Castro AJ, Ruiz-Padilla AJ, Ortiz-Cortes M, Carranza E, Ramírez-Morales MA, Escutia-Gutiérrez R, et al. Self-treatment and adverse reactions with herbal products for treating symptoms associated with anxiety and depression in adults from the central-western region of Mexico during the Covid-19 pandemic. J Ethnopharmacol. 2021;272:113952. doi: 10.1016/j.jep.2021.113952.
Kennedy DA, Hart J, Seely D. Cost effectiveness of natural health products: a systematic review of randomized clinical trials. Evid Based Complement Alternat Med. 2009;6(3):297–304. 10.1093/ecam/nem167.
Witteveen D, Velthorst E. Economic hardship and mental health complaints during COVID-19. Proc Natl Acad Sci U S A. 2020;117(44):27277–27284. 10.1073/pnas.2009609117.
Mejia CR, Rodriguez-Alarcon JF, Garay-Rios L, et al. Perception of exaggeration or fear propagated by the media among the Peruvian population during the COVID-19 pandemic. Rev Cubana Invest Bioméd. 2020;39(2):e698. http://www.revibiomedica.sld.cu/index.php/ibi/article/view/698.
Tuccori M, Convertino I, Ferraro S, Cappello E, Valdiserra G, Focosi D, et al. The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance. Drug Saf. 2020;43(8):699–709. 10.1007/s40264-020-00965-w.
LeRoy AS, Robles B, Kilpela LS, Garcini LM. Dying in the face of the COVID-19 pandemic: Contextual considerations and clinical recommendations. Psychol Trauma. 2020;12(S1):S98–S99. doi: 10.1037/tra0000818.
Agbabiaka TB, Wider B, Watson LK, Goodman C. Concurrent Use of Prescription Drugs and Herbal Medicinal Products in Older Adults: A Systematic Review. Drugs Aging. 2017;34(12):891–905. doi: 10.1007/s40266-017-0501-7.
Meshesha SG, Yeshak MY, Gebretekle GB, Tilahun Z, Fenta TG. Concomitant Use of Herbal and Conventional Medicines among Patients with Diabetes Mellitus in Public Hospitals of Addis Ababa, Ethiopia: A Cross-Sectional Study. Evid Based Complement Alternat Med. 2020;2020:4871459. doi: 10.1155/2020/4871459.
Posadzki P, Watson L, Ernst E. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol. 2013;75(3):603–618. doi: 10.1111/j.1365-2125.2012.04350.x.
Britza SM, Musgrave IF, Byard RW. Paracetamol (acetaminophen) hepatotoxicity increases in the presence of an added herbal compound. Leg Med (Tokyo). 2020;47:101740. doi: 10.1016/j.legalmed.2020.101740.
Chatfield K, Salehi B, Sharifi-Rad J, Afshar L. Applying an Ethical Framework to Herbal Medicine. Evid Based Complement Alternat Med. 2018;2018:1903629. doi: 10.1155/2018/1903629.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2023 Fabricio Ccami-Bernal, Cristhian Rojas-Miliano, David R. Soriano-Moreno; Daniel Fernández-Guzmán; Carlos Quispe-Vicuña, Enrique A. Hernández- Bustamante, Elvira G. Zamora-Huaringa, Wendy Nieto-Gutiérrez
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Cómo citar
